Sp-8356, emodin, and it603 enhance beige adipocyte activity and alleviate obesity and diabetes via uncoupling protein 1 (ucp1)-independent mechanism
AssigneeThe Chinese University of Hong Kong
InventorsXiaoyan HUI, Jiaxing LIU, Qing LIU
Life of this patent
Estimating the term…
Abstract
The subject invention pertains to compositions and methods for the activation of beige adipocytes. The subject invention further pertains to methods of treating obesity, diabetes, and metabolic diseases. In certain embodiments, the subject composition comprises SP-8356 or a derivative thereof, emodin or a derivative thereof, IT603 or a derivative thereof, or any combination thereof.
Claims19
A method of activating beige adipocytes comprising administering an effective amount of a composition comprising SP-8356 or a derivative thereof, emodin or a derivative thereof, IT603 or a derivative thereof, or any combination thereof to a subject.
A composition comprising SP-8356 or a derivative thereof, emodin or a derivative thereof, IT603 or a derivative thereof, or any combination thereof.
Dependencies are inferred from the claim text.